Report Highlights
The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.
Report Includes
- 27 tables
- An overview of the global market and technologies for microbial products with special focus on their applications
- Estimation of the market size and analyses of global market trends, with data from 2019-2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential and quantification of microbial products market based on type, application, and region
- Detailed descriptions of probiotics, their types, and recent developments and information on microbial pesticides and biofertilizers and their potential uses
- Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players of the industry, including Seres Therapeutics, Enterome Biosciences, Ferring Pharmaceutics, Evelo Biosciences, Finch Therapeutics, Microbiome Therapeutics, and Pylum Biosciences
Report Scope
This report addresses the global market for microbes and microbial products used in commercial applications from 2021 through 2027. This includes agricultural, healthcare, manufacturing, energy, and environmental applications.
Viruses are sometimes classified as microbes, but they are nonliving, and thus they are excluded from this report.
Major elements cited in this study include:
- Summary.
- Definitions.
- Description of microbes.
- Microbe end-uses and applications.
- Regulation.
- Recent technological developments.
- Market size and segmentation from 2021 to 2027.
- Company profiles.
- Key patents.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $229.9 billion | ||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $346.3 billion | ||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 7.4% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||||||
| Segments covered | Segment, product type, end-use, region | ||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||||||||||||||||||||||||||||||
| Countries covered | United States, Canada, Germany, France, U.K., Spain, Italy, Russia, China, India, Japan, South Korea, Australia, and Singapore | ||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
- Novozymes
- Lam International
- Amgen
- Novo Nordisk
- Evolva
- Amyris
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.
Report Includes
- 29 data tables and 21 additional tables
- An overview of the global market for microbial products, technologies, and applications
- Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Identifications of microbial applications in a wide range of fields, i.e., agriculture, healthcare, manufacturing, energy, and environment
- Information about microbial pesticides and biofertilizers and their potential uses
- Detailed descriptions of probiotics, their types, and recent developments
- Coverage of microbial fuel cell technologies and their types, i.e., mediator microbial fuel cells, microbial electrolysis cells, soil-based microbial fuel cells, phototropic biofilm microbial fuel cells, and nanoporous membrane microbial fuel cells
- Comprehensive company profiles of major players in the market, including Certis USA LLC, Taiwan Chlorella Manufacturing Co., Amgen Inc., Leadiant, AB Mauri, Genencor, and Amyris Inc.
Report Highlights
The global market for microbes and microbial products was valued at $143.5 billion in 2014. The 2015 market is projected to approach $154.7 billion, and the 2020 market, nearly $306 billion, with a compound annual growth rate (CAGR) of 14.6% from 2015 to 2020.
Report Includes
- An overview of the global market for microbial products, technologies and their applications.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Identifications of microbial applications in a wide range of fields, the applications and end uses that appear to have significant commercial potential in the near to mid-term, and quantitative estimates of their current and/or future sales.
- Examination of market drivers, regulations, and recent technological developments.
- Information gathered from developers, vendors, and users of microbial products for commercial applications.
- Comprehensive company profiles of major players.
Report Highlights
The total global market for microbes and microbial products was worth more than $117 billion in 2012. The 2013 market is projected to approach $134 billion, and, by 2018, $179 billion, with a projected five year compound annual growth rate (CAGR) of 6%.
Report Includes
- An overview of the global market for microbes and microbial products.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identifications of microbial applications in a wide range of fields, the applications and end uses that appear to have significant commercial potential in the near to mid-term, and quantitative estimates of their current and/or future sales.
- Examination of market drivers, regulations, and recent technological developments.
- Comprehensive company profiles of major players.
Report Highlights
The total global market for microbes and microbial products was worth more than $144 billion in 2010. The 2011 market is projected to exceed $156 billion, and, by 2016, $259 billion, reflecting a 10.7% projected compound annual growth rate (CAGR) between 2011 and 2016.
Related Reports
Global Algae and Seaweed Protein Market
The global market for algae and seaweed protein reached $904.7 million in 2022. The market is estimated to grow from $962.8 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 6.8% from 2023 through 2028.
Microbiome Therapeutics: Global Markets
The global market for microbiome therapeutics is estimated to increase from $164.8 million in 2022 to reach $1.5 billion by 2027, at a compound annual growth rate (CAGR) of 54.8% from 2022 through 2027.
Global Yeast Derivative Market
The global market for yeast derivative should grow from $2.1 billion in 2021 to $3.1 billion by 2026, at compound annual growth rate (CAGR) of 7.7% for the period of 2021-2026.
Top Ten Bioremediation Companies
This report provides detailed information on companies that BCC Research has identified as market leaders. These companies are selected based on revenue, innovations, strength of product portfolio, regional presence, investment capacity and similar other factors. The report also provides brief information and overview of the global bioremediation market.
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More